A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Published:2015-06-09 Issue:08 Volume:76 Page:1085-1090
ISSN:0160-6689
Container-title:The Journal of Clinical Psychiatry
language:
Short-container-title:J. Clin. Psychiatry

Author:

Meltzer Herbert Y.,Risinger Robert,Nasrallah Henry A.,Du Yangchun,Zummo Jacqueline,Corey Lisa,Bose Anjana,Stankovic Srdjan,Silverman Bernard L.,Ehrich Elliot W.

Publisher

Physicians Postgraduate Press, Inc

Subject

Psychiatry and Mental health

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia;The Journal of Clinical Psychiatry;2024-02-28

2. Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes;Biomedicines;2024-01-12

3. Comparative Safety of Long-Acting Injectable Antipsychotics: A Systematic Review and Network Meta-Analysis;Psychiatry Investigation;2023-12-25

4. Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety;Neuropsychiatric Disease and Treatment;2023-10

5. Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis;European Neuropsychopharmacology;2023-07